(VIANEWS) – The NASDAQ opens in less than five hours and Inovio Pharmaceuticals‘s pre-market value is already 16.18% up.
The last session, NASDAQ ended with Inovio Pharmaceuticals (INO) dropping 3.35% to $1.73. NASDAQ dropped 1.33% to $11,028.74, after four sequential sessions in a row of losses, on what was an all-around down trend trading session.
Today’s last reported volume for Inovio Pharmaceuticals is 5699353, 10.06% below its average volume of 6336901.
Inovio Pharmaceuticals’s last close was $1.73, 82.63% below its 52-week high of $9.96.
Inovio Pharmaceuticals’s Sales
Inovio Pharmaceuticals’s sales growth is 138.1% for the ongoing quarter and a decline by 33% for the next. The company’s growth estimates for the present quarter is 17.9% and a drop 3.4% for the next.
Inovio Pharmaceuticals’s last day, last week, and last month’s current intraday variation average was 3.47%, 3.28%, and 4.64%, respectively.
Inovio Pharmaceuticals’s highest amplitude of average volatility was 9.52% (day), 8.85% (last week), and 9.20% (last month), respectively.
More news about Inovio Pharmaceuticals (INO).